Clinical trial
Effect of High-Dose B-Complex Vitamins on the Symptoms of Schizophrenia
NCT00403247 · Nathan Kline Institute for Psychiatric Research, Other · Completed
Key facts
| NCT number | NCT00403247 |
|---|---|
| Title | Effect of High-Dose B-Complex Vitamins on the Symptoms of Schizophrenia |
| Official title | Double-Blind Vitamin Intervention to Lower Blood Homocysteine Levels: Amino Acid and Clinical Responses in Individuals With Schizophrenia. |
| Lead sponsor | Nathan Kline Institute for Psychiatric Research, Other |
| Collaborators | Stanley Medical Research Institute |
| Status | Completed |
| Study type | Interventional |
| Conditions | Schizophrenia, Schizoaffective Disorder |
| Intervention type | Dietary Supplement, Other |
| Interventions | Capsule with folate, Vitamin B12 & pyridoxine, placebo |
| Enrollment | 50 |
| Start date | Jul 1, 2004 |
| Completion | Jul 1, 2007 |
| First posted | Nov 23, 2006 |
| Last update posted | Aug 23, 2007 |
| Countries | United States |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: